Former WHO flu vaccine chief, Klaus Stohr, to head up Novartis’ flu vaccine development program

This article, from the New Scientist, with the news.

pharmamanufacturing

Jan. 29, 2007

This article, from the New Scientist, with the news.

About the Author

pharmamanufacturing

pharmamanufacturing

Related

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

‘Cobots’ drive pharma’s shift toward scalable cell therapies

‘Cobots’ drive pharma’s shift toward scalable cell therapies

OnTrak Wireless: Total Bearing Health Solution

Sponsored

OnTrak Wireless: Total Bearing Health Solution

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Trending

FDA launches pilot to speed up review for US generic drug manufacturing, testing

Flexibility and scalability are critical to the success of cell and gene therapy manufacturing

Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old

Recommended

Ultrasound Power: OnTrak Wireless Detects Bearing Faults Earlier

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Early Intervention with OnTrak Wireless for High-Heat Environments